<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Serati M</dc:creator>
  <dc:creator>Braga A</dc:creator>
  <dc:creator>Cantaluppi S</dc:creator>
  <dc:creator>Caccia G</dc:creator>
  <dc:creator>Ghezzi F</dc:creator>
  <dc:creator>Sorice P</dc:creator>
  <dc:date>2018</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">INTRODUCTION AND HYPOTHESIS
The aim of this study was to assess the safety and efficacy of vaginal native tissue repair and uterine suspension after a follow-up of at least 1 year.


METHODS
We included all consecutive women with an anterior vaginal prolapse of stage II or higher and a concomitant uterine prolapse of stage II who underwent this surgical procedure. We considered women with a descensus with maximum point of less than -1 in any compartment as objectively cured. Overall success was defined as no prolapse symptoms, together with a Patient Global Impression of Improvement (PGI-I) score of 2 or less, prolapse of stage lower than II, and no need for other surgery.


RESULTS
A total of 102 patients underwent this surgical procedure during the study period and met all the inclusion criteria for statistical analysis. The mean follow-up was 31 ± 8.2 months; no patient was lost to follow-up. Five patients (4.9%) showed postoperative complications. In terms of subjective outcomes, at the last available follow-up, failure of this surgical procedure was seen in 2% of patients. The objective cure rate and the overall cure rate were the 95.1%. No significant deterioration in objective cure rates was observed over time (p = 0.6).


CONCLUSIONS
Vaginal repair and hysteropexy appear to be an effective and safe option for women with advanced uterovaginal prolapse.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/279192</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s00192-017-3498-x</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/29064031</dc:relation>
  <dc:source>International urogynecology journal. - 2018</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Cystocele</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Hysteropexy</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Pelvic organ prolapse (POP)</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Transverse cystocele repair</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Cystocele</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Follow-Up Studies</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Gynecologic Surgical Procedures</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Italy</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Postoperative Complications</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Pregnancy</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Prospective Studies</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Quality of Life</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Surgical Mesh</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Treatment Outcome</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Uterine Prolapse</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Vagina</dc:subject>
  <dc:title xmlns:ns20="xml" ns20:lang="en">Vaginal cystocele repair and hysteropexy in women with anterior and central compartment prolapse: efficacy and safety after 30 months of follow-up.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>